Astellas Pharma Inc (ALPMY)
10.04
+0.07
(+0.70%)
USD |
OTCM |
May 03, 16:00
Astellas Pharma Total Liabilities (Quarterly): 13.23B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 13.23B |
September 30, 2023 | 12.74B |
June 30, 2023 | 8.422B |
March 31, 2023 | 7.119B |
December 31, 2022 | 7.196B |
September 30, 2022 | 6.466B |
June 30, 2022 | 6.902B |
March 31, 2022 | 7.145B |
December 31, 2021 | 7.734B |
September 30, 2021 | 7.538B |
June 30, 2021 | 7.839B |
March 31, 2021 | 8.045B |
December 31, 2020 | 9.000B |
September 30, 2020 | 8.587B |
June 30, 2020 | 8.823B |
March 31, 2020 | 9.494B |
December 31, 2019 | 6.174B |
September 30, 2019 | 6.333B |
June 30, 2019 | 6.277B |
March 31, 2019 | 5.765B |
December 31, 2018 | 5.764B |
September 30, 2018 | 5.315B |
June 30, 2018 | 5.344B |
March 31, 2018 | 5.551B |
December 31, 2017 | 5.029B |
Date | Value |
---|---|
September 30, 2017 | 4.843B |
June 30, 2017 | 5.191B |
March 31, 2017 | 4.850B |
December 31, 2016 | 4.646B |
September 30, 2016 | 4.800B |
June 30, 2016 | 4.894B |
March 31, 2016 | 4.806B |
December 31, 2015 | 3.864B |
September 30, 2015 | 3.733B |
June 30, 2015 | 3.637B |
March 31, 2015 | 3.963B |
December 31, 2014 | 3.998B |
September 30, 2014 | 3.840B |
June 30, 2014 | 3.810B |
March 31, 2014 | 3.737B |
December 31, 2013 | 3.858B |
September 30, 2013 | 3.827B |
June 30, 2013 | 3.876B |
March 31, 2013 | 4.149B |
December 31, 2012 | 4.267B |
September 30, 2012 | 4.073B |
June 30, 2012 | 4.436B |
March 31, 2012 | 4.689B |
December 31, 2011 | 4.700B |
September 30, 2011 | 4.519B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.174B
Minimum
Dec 2019
13.23B
Maximum
Dec 2023
8.161B
Average
7.734B
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 53.04B |
Nxera Pharma Co Ltd | 640.94M |
PeptiDream Inc | 206.45M |
Stemcell Holdings Inc | 6.023M |
Healios KK | 80.04M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 23.89B |
Shareholders Equity (Quarterly) | 10.66B |
Debt to Equity Ratio | 0.5794 |
Current Ratio | 0.9102 |
Net Debt Paydown Yield | -5.79% |